Browsing by Subject "3,4-Dihydroxyphenylacetaldehyde"
Now showing items 1-1 of 1
-
(Medknow Publications & Media Pvt, 2017)For 50 years ago was introduced L-3,4-dihydroxyphenylalanine (L-dopa) in Parkinson's disease treatment and during this significant advances has been done but what trigger the degeneration of the nigrostriatal system remain ...